Cargando…
Inflammatory biomarkers at hospital discharge are associated with readmission and death in patients hospitalized for COVID-19
Autores principales: | Slim, Marleen A., Appelman, Brent, Müller, Marcella C. A., Brouwer, Matthijs C., Vlaar, Alexander P. J., Wiersinga, W. Joost, van Vught, Lonneke A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8552978/ https://www.ncbi.nlm.nih.gov/pubmed/34713349 http://dx.doi.org/10.1007/s10096-021-04355-7 |
Ejemplares similares
-
Real-world Evidence of the Effects of Novel Treatments for COVID-19 on Mortality: A Nationwide Comparative Cohort Study of Hospitalized Patients in the First, Second, Third, and Fourth Waves in the Netherlands
por: Slim, Marleen A, et al.
Publicado: (2022) -
Mortality and readmission rates among hospitalized COVID-19 patients with varying stages of chronic kidney disease: a multicenter retrospective cohort
por: Appelman, Brent, et al.
Publicado: (2022) -
Personalised immunotherapy in sepsis: a scoping review protocol
por: Slim, Marleen A, et al.
Publicado: (2022) -
Death and readmissions after hospital discharge during the December holiday period: cohort study
por: Lapointe-Shaw, Lauren, et al.
Publicado: (2018) -
Time since SARS-CoV-2 infection and humoral immune response following BNT162b2 mRNA vaccination
por: Appelman, Brent, et al.
Publicado: (2021)